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Abstract 
Due to the advent of allopathy and concomitant usage of the medicinal drugs with herbal 
medicines, many herb drug interactions are increasingly reported in the scientific literature. In 
this study, we have collected the scientific literature in the field of herb drug interactions 
published between 2011 to 2019 and analyzed it for the scientometric trends to understand the 
research direction in the last decade. We analyzed for the most prolific authors and their 
affiliations, top ten countries, funding agencies that sponsored the most publications and 
journals with most articles published in the field of herb drug interactions. We also identified 
three top articles of the field, two out of which made it to the list of top articles (based on 
citation count) of all time. We have identified upcoming research trend of network analysis and 
systems biology approach in the broad field of herbal medicines and application into the field 
of herb drug interactions. Our study demonstrated a dominant role of China and authors 
working in Chinese institutions (research output measured through analysis of publications, 
author contributions and grant fundings) in the field of herb drug interactions. As use of 
allopathy and herbal medicines together is on the rise worldwide, we predict that herb drug 
interactions will become an important concern in the future and precise regulatory guidelines 
must be developed worldwide as soon as possible.  
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Introduction 
In today’s world, traditional medicines are used by over sixty percent of the world’s population. 
Interestingly, a huge proportion of their consumers are present in developed countries even 
though out of developing countries, China and India are still the leaders for traditional 
medicinal systems. Nearly 40 percent of Chinese and approximately seventy percent of Indian 
population uses traditional medicinal systems for treatment and about, 11,146 and 20,000 
medicinal plants have been recorded with curative potential in China and India, respectively. 
Currently, 8000 traditional Chinese herbal medicines and more than 10,000 Indian herbal 
preparations (including Ayurvedic, Siddha, Unani, Homeopathic, Tibetan and folk 
preparations) are available (1-3). Owing to the arrival of allopathy, people are using these 
herbal treatments in conjunction with allopathic drugs resulting in herb-drug interactions. The 
occurrence of herb-drug interactions is due to absence of awareness in general public as well 
as limited reported scientific evidence available with the regulatory authorities. Many herb 
drug interactions have recently become available in the literature (4-6). A retrospective 
population-based study on adults that were given Ginkgo biloba alone or in combination with 
anti-coagulant drugs displayed increased risk of haemorrhage in male patients aged 65 and 
above (7). An Indian herb, Momordica charantia (popularly known as karela) has synergistic 
interactions with four oral hypoglycaemic agents (Rosiglitazone, Metformin, Glibenclamide, 
and Chlorpropamide) and administration of the herb and the drug together results in excessive 
lowering of body blood glucose levels (8, 9).  
Still, many herb-drug interactions are either under-reported or not yet known because they are 
largely confused with drug side-effects. As a large portion of world population is using herbs 
for treatment or symptomatic cure and is thus, at risk, of adverse effects due to reported or not 
yet reported herb-drug interactions, this field requires considerable attention by the scientific 
community. To assess if this is the case, we aimed to study the scientometrics about herb drug 
interactions in the last nine years i.e. 2011-2019. We collected data from SCOPUS and 
analyzed it for top authors, top funding agencies, top countries, top journals and top author 
affiliations in the field of herb drug interactions. We also analyzed the top three articles of this 
era to identify the upcoming research trend. 
Methodology 
Data acquisition and scientometry indicators assessment 
We selected SCOPUS as a valid source for retrieval of data used for this scientometric analysis.  
SCOPUS is the main international database for health sciences, and the terminology included 
in its thesaurus can be used to search for published documents on specific aspects of a given 
topic. A search with words ‘herb drug interactions’ as descriptor was performed for the years 
2011-2019 to retrieve publications that contained these words in publications’ titles, keyword 
lists, and abstracts (selection setting in the SCOPUS portal). Although it is possible that there 
may be other terminologies, the search terms were kept broad to ensure that all the right 
matches would be included. To refine the search results, document type articles or reviews was 
selected and other document types such as book chapter, data paper, proceedings abstracts were 
excluded. Once the search was complete, all the documents were selected and data for citation 
information (author(s), document title, year, source title, volume, issue, pages, citation count, 
source & document type), bibliographical information (affiliations, serial identifiers (e.g. 
ISSN), PubMed ID, publisher, editor(s), language of original document, correspondence 
address, abbreviated source title, DOI), abstract & keywords (abstract, author keywords, index 
keywords), funding details (number, acronym, sponsor, funding text) was exported as CSV 
files for subsequent analyses. The electronic search was performed in November, 2019 and 
record of articles (original and review) with a total of 4,183 was retrieved. No restriction based 
on language of articles was made although only a small percentage of total articles was non-
English (<8%). The above data was further assessed for identifying the most cited articles, 
highest published researchers/authors, most influential funding agencies and countries.  
Results 
To assess the trend in the field of herb-drug interactions, we performed a search in SCOPUS 
using the terms ‘herb drug interactions’ limited to original articles and review publication types 
published between years 2011-2019. The search was performed to include the searched term 
whenever it appeared in abstract, title of the publication and keywords. The data obtained was 
assessed for indicators of scientometry such as trends in publications over the years, countries 
with most prolific authors, funding agencies with most contributions in form of funding for 
research and so forth.  
Our assessment of the publications between years 2011-2019 demonstrated that the number of 
publications has remained consistent throughout the years studied. No significant rise was 
observed in the last 10 years with the majority of publications lying between 260 (in 2011) and 
330 (in 2018) (Fig 1). 
[Fig 1 here] 
Although no trend could be identified in the number of publications in Fig 1, an assessment of 
publications according to countries displayed China as the leader on herb drug interactions with 
1208 publication, approximately half of the recorded publications (Fig 2). This is no surprise 
as China is a world leader in traditional medicine (10). United States closely followed with 916 
publications and, interestingly, authors from India, another hub for traditional medicinal 
systems (Ayurveda, Siddha and Unani), have published comparatively smaller number of 
publications (257) between 2011 and 2019. The variation in the total number of publications 
between Fig 1 and Fig 2 arises from collaborations between authors from different countries 
although only top 10 countries have been analyzed in Fig 2.  
[Fig 2 here] 
A bar graph analysis of sponsoring agencies funding the grants, associated with recorded 
publications, demonstrated that six out of the top ten funding agencies were located in China 
(Fig 3). This may explain the results obtained in Figure 2. NNSF or National Natural Science 
Foundation of China, affiliated to China’s State Council, topped the list with 372 publications, 
seven times as high as the closest competitor NBRP (973) or National Basic Research Program 
of China (973 program). Although USA led the publications in the country wise analysis with 
916 publications, only one USA funding agency i.e. NIH or National Institutes of Health made 
it to the top ten. Furthermore, even if India came in third with 257 publications, none of the 
Indian research funding agencies made it to the top 10 list. 
[Fig 3 here] 
A similar bar-graph analysis for top 10 journals displayed Journal of Ethnopharmacology 
surpassed other journals with 176 publications closely followed by Phytotherapy Research with 
104 publications and Evidence Based Complementary and Alternative Medicine with 78 
publications during 2011-2019 (Fig 4).  
[Fig 4 here] 
Bar graph for top 10 author affiliations (Fig 5) showed Chinese Academy of Sciences (CAS 
China; 118 publications) as the leader in the field of herb-drug interactions between 2011-2019, 
closely followed by Chinese University of Hong Kong (CU Hong Kong; 106 publications) and 
Ministry of Education China (ME China; 81 publications). 
[Fig 5 here] 
E. Ernst led the list of top 10 authors with 31 publications in 2011 to 2019-year range while M. 
Huang (23), Y. C. Hou (22), S.F. Zhou (21) and J.A. Duan (20) published 20-23 articles in the 
same time-period (Table 1). 
[Table 1 here] 
In addition, an analysis of the top three articles in our search identified three articles, published 
during 2013-2014, as the most cited articles (Table 2). These articles were “Structure and 
dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive 
review”, “A review on therapeutic potential of Nigella sativa: A miracle herb” and “TCMSP: 
A database of systems pharmacology for drug discovery from herbal medicines” with citation 
counts of 445, 339 and 297 respectively. Interestingly, none of these articles could be attributed 
to the identified top authors in table 1.  
[Table 2 here] 
Discussion 
As a considerable number of people, even westerners, are turning towards herbal medicines, 
herb-drug interactions are increasingly gaining public interest. As of now, testing of herb drug 
interactions is not an essential part of allopathic drug development process and therefore, these 
interactions are easily missed. China and India are important regions for local traditional 
medicinal systems and the advent of allopathy has resulted in increased probability of herb 
drug interactions in these countries. Perceiving the need for interaction testing, China have 
been world leaders in this field as evident from the publication count and funding for research 
as observed in our collected data. Almost half of the publications (1208) were authored or co-
authored by Chinese authors (Fig 2). It was surprising that although India is a hub for traditional 
medicine too (such as Ayurveda), Indian authors authored or co-authored only 257 
publications. As our data is based on SCOPUS search, we cannot rule out the possibility of 
Indian researchers publishing in non-SCOPUS indexed journals. In addition, India has local 
journals, many of which are not SCOPUS indexed. We did observe a variation in the 
publication count between Figure 1 and Figure 2 which could be based on collaborations 
between authors from different nationalities. This would explain the publication count of 2124 
for China (1208) and USA (916) and indicate huge number of China-USA collaborations in 
the field of herb-drug interactions. The high amount of Chinese researchers-authored 
publications also correlates with the six funding agencies being Chinese as shown in figure 3. 
Interestingly, only one funding agency, NIH, has been involved in funding USA based research 
in this field and none of the Indian funding agencies made it to the list of top ten funding 
sponsoring agencies. This may indicate a regional bias for research area and possibility that 
while China heavily invested in identifying possible drug interactions with herbs used in 
traditional Chinese medicines and American scientists, therefore, heavily collaborated with 
them, Indian funding agencies channelized their funds on other areas of biological sciences.  
Journal of Ethnopharmacology, Phytotherapy Research and Evidence Based Complementary 
and Alternative Medicine published the highest number of research and review articles on herb 
drug interactions between 2011 and 2019 as shown in Figure 4. Majority of the journals in the 
top ten are natural medicine-based journals. Although any herb drug interaction report is 
equally important both for readers and scientific community working on herbal medicines as 
well as allopathy, this may result in unequal distribution of scientific reporting. According to 
our collected data, few allopathy-based journals publish reports of herb drug interactions. Our 
data from Figure 5 confirmed the finding that most of the publications were co-authored by 
Chinese researchers as majority of affiliations were located in China and displayed the highly 
collaborative attitude of Chinese researchers in the field of herb drug interactions. Interestingly, 
E. Ernst, an author working in United Kingdom and not working in China, topped the list of 
authors with 31 publications (Table 1). He is affiliated with Department of Complementary 
Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, Exeter, 
United Kingdom and all his 31 publications were funded by National Center for 
Complementary and Alternative Medicine (NCCAM), USA and National Health Service 
(NHS), U.K. (data through assessment of author’s profile from scientific database online). 
Also, four publications authored by E. Ernst made it to the top 20 publications of all-time list 
(Suppl Table 1). Top three authors also include M. Huang, China (23) and Y.C. Hou, Taiwan 
(22). Five Chinese authors (Table 1) made it to the top 10 list while no Indian authors made it 
to the list. Other authors, S.F. Zhou, Hong kong (21), B.J Gurley, USA (19) and T.H Tsai, 
France (19) were also included in the top authors list.  
An analysis of top three articles published during 2011-2019, based on citation count, indicated 
that novelty has gained importance in the last decade. It is surprising that although these articles 
were published comparatively recently, two of the top articles of the assessed years made it to 
the list of top 20 articles of all time (Suppl Table 1). Not surprisingly, All the top three articles 
are review articles. Also, 14 articles in the top publication of all-time list are review articles 
indicating that review articles are cited more frequently than research articles (Supple Table 
1). Two of these articles, namely, “Structure and dynamics of molecular networks: a novel 
paradigm of drug discovery: a comprehensive review” and “TCMSP: A database of systems 
pharmacology for drug discovery from herbal medicines” utilized and merged upcoming 
scientific areas such as molecular networks and database mapping. Both these articles set a 
precedent in the broader field of biological sciences and demonstrated the application of online 
databases and network analysis in herb drug interactions. All the three articles (Table 2) have 
included the term herb drug interactions in that met are search criteria (see methodology section 
for detailed search parameters). 
The review article titled “Structure and dynamics of molecular networks: a novel paradigm of 
drug discovery: a comprehensive review” published in 2013 in the Journal ‘Pharmacology & 
Therapeutics’ is a comprehensive review on molecular networks and possible application in 
drug discovery. The article has been cited by 445 publications till our search. The article 
performed a comprehensive assessment of the analytical tools of network topology and 
dynamics. The two basic strategies for network targeting i.e. central hit strategy and network 
influence strategy have been described and their role in identification of single-target, edgetic, 
multi-target and allonetwork drug target candidates have been discussed. This 190-page article 
describes important tools to study and identify molecular networks and their role in diseases 
and possible targeting in cancer and diabetes. Although this article is important for drug 
discovery and development per se, it has acted as a breakthrough for herb-based drug 
development too. Drug-drug interactions as a measure of network interactions with a direct 
reference to online databases has been discussed. Interestingly, use of networks to assess herb-
drug interactions has resulted through the networks or interaction partners that were identified 
through this approach. Many interactions such as herb CYP450 interactions (11-13). Although 
the term herb drug interactions has been vaguely mentioned in the articles that have cited this 
review article, many articles are too broad to categorize under a specific category. However, 
as this approach shows promise in identifying herb-drug or herb-CYP (effect on drug 
metabolism) in the field, its role as a milestone cannot be disputed. 
The article titled “TCMSP: A database of systems pharmacology for drug discovery from 
herbal medicines” describes a free online platform that converges information of 
pharmacochemistry, ADME properties, drug-likeness, drug targets, associate diseases and 
interaction networks for traditional Chinese medicine. The database indirectly aims at widening 
the understanding of mechanism of actions for Chinese herbal medicines and possible herb 
targets inclusive drug interactions and provides tools for visualization at the network level. 
This article has acted as a milestone for many research articles published on network 
pharmacology of Chinese herbal medicines in later years (14-16). Network pharmacology has 
been further explored for disease specific herbal treatments and targets such as in 
neurodegenerative diseases (17, 18), hepatoma and hepatoprotective mechanisms (19-21), 
vitiligo (22), cardiovascular diseases (19, 23), diabetes mellitus (24) and many more. Attempt 
to identify new herbal drug candidates for cancer therapy (25) and explain herb combinations 
in a concoction have also been performed (26). All the above approaches have thus identified 
herb phytoconstituent targets which may be shared by allopathic drugs as well as herb effects 
on the body’s metabolic enzymes such as CYP450s. 
Review article titled “A review on therapeutic potential of Nigella sativa: A miracle herb” 
published in 2013 also made it to top articles of all time with 339 citations during our analysis. 
This article is a collaboration between Indian authors and authors working in the middle east. 
Nigella sativa is a widely used medicinal plant especially in middle eastern and Indian 
traditional systems. Its pharmacological properties have been explored as an anti-diabetic, anti-
cancer, immunomodulator, analgesic, antimicrobial, anti-inflammatory, spasmolytic, 
bronchodilator, hepatoprotective, renal protective, gastroprotective and anti-oxidant and the 
review describes a detailed literature survey on Nigella sativa pharmacognostical 
characteristics, chemical composition and pharmacological activities of the seeds of the plant. 
In our understanding, the topic covered in this review is very broad and thus the chances of the 
citation increase considerably. Therefore, the review has been extensively cited in research and 
review articles that discuss the herb directly (27-30) or vaguely mention connected topics (31-
34). This review article has discussed the possible Herb drug interactions for Nigella sativa. 
These publications demonstrate an open and collaborative attitude of research scientists 
working the field of herb drug interactions and a paradigm shift to include new age methods in 
science. Finally, our study demonstrates a dominant role of China (research output measured 
through analysis of publications, author contributions and grant fundings). It is unfortunate that 
a similar trend could not be observed for other countries invested in usage of traditional herbal 
medicines resulting in a research gap in these medicinal systems. 
Conclusion 
In this scientometric study, we have identified China as the leader in the field of herb-drug 
interactions with almost half of publication authored or co-authored by Chinese researchers in 
SCOPUS indexed journals. Six Chinese researchers made it to the top ten prolific authors list 
for the period of 2011 to 2019. We also found that China is leading in the funding provided to 
researchers with six Chinese funding agencies listed in the top 10. Although important 
traditional medicinal systems such as Ayurveda and Siddha are localized in India, the 
publication count and absence of Indian authors and funding agencies in the top ten indicates 
a regression on identification and implementation of information on herb drug interactions 
locally. The same scenario is envisaged for other countries with prolific users of traditional 
medicinal systems (e.g. Brazil). As use of allopathy and herbal medicines together is on the 
rise worldwide, we predict that herb drug interactions will become an important concern in the 
future and precise regulatory guidelines must be developed worldwide as soon as possible. Our 
literature analysis proves a steady output of publications in the field although better research 
output is observed for Chinese traditional medicines than other systems. A similar attitude must 
be adopted by other countries that heavily bank on traditional medicines and herb drug 
interaction testing should be made an important part of any drug development. 
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 Figure 1 2011-2019 trend in publications on herb drug interactions. SCOPUS search 
on ‘herb drug interactions’ for original articles and review articles between 2011 to 2019 
were plotted in to a bar-graph and assessed for possible trends in research. 
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 Figure 2 Trend in publication count for the top 10 countries. Bar graphs were prepared 
for the identified top 10 countries leading the ‘herb drug interactions’ field in 2011-2019 
time period. 
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NNSF China National Natural Science Foundation of 
China, China’s State Council, China 
CNDCT Brazil Conselho Nacional de Desenvolvimento 
Científico e Tecnológico (National Council 
for Scientific and Technological 
Development), Brazil 
NBRP (973) China National Basic Research Program of China 
(973 program), China 
NIH USA National Institutes of Health, U.S. 
Department of Health & Human Services. 
USA 
NRF Korea National Research Foundation of Korea, 
South Korean Ministry of Culture and 
Tourism, South Korea 
NSC Taiwan National Science Council, Taiwan 
FRFCU China Fundamental Research Funds for the Central 
Universities, China 
MoST China Ministry of Science and Technology of the 
People’s Republic of China, China 
PAPDJHEI China Priority Academic Program Development of 
Jiangsu Higher Education Institutions, China 
CAS China Chinese Academy of Sciences, China 
 
Figure 3 Bar graph analysis of top 10 funding agencies. Top 10 funding agencies that 
financed the highest number of publications in the field of ‘herb drug interactions’ were 
identified and plotted on a bar graph for the years 2011-2019. Full names of funding 
agencies with abbreviations used in graph are given in the table. 
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Journal acronym Journal full name Location 
J Ethnopharmacol Journal of Ethnopharmacology Netherlands 
Phytother Res Phytotherapy Research United States 
Evid Based 
Complement 
Alternat Med 
Evidence Based Complementary and 
Alternative Medicine 
Egypt 
Phytomedicine Phytomedicine Germany 
Planta Med Planta Medica Germany 
Lat Am J Pharm Latin American Journal of Pharmacy Argentina 
BMC Complem 
Altern M 
BMC Complementary and Alternative 
Medicine 
United Kingdom 
Molecules Molecules Switzerland 
Food Chem Toxicol Food and Chemical Toxicology Netherlands 
 
Figure 4 Top 10 Journals in the field of herb drug interactions during 2011-2019. Journals 
were classified into top 10 journals on the basis of publication count and plotted in a bar graph. 
Full journal names with abbreviations used in graph are given in the table. 
  
0
20
40
60
80
100
120
140
160
180
200
N
o
. o
f 
P
u
b
lic
at
io
n
s
 
Abbreviations Full affiliations 
CAS China 
 
Chinese Academy of Sciences, Beijing, China 
 
CU Hong 
Kong 
 
Chinese University of Hong Kong, Sha Tin, Hong Kong 
ME China Ministry of Education China, Beijing, China 
NUTCM China Nanjing University of Traditional Chinese Medicine, 
Jiangsu, China 
CMUT Taiwan China Medical University, Taichung, Taiwan 
SUTCM China Shanghai University of Traditional Chinese Medicine, 
Shanghai, China 
CPU China China Pharmaceutical University, Jiangsu, China  
 
CACMS China China Academy of Chinese Medical Sciences, Beijing, 
China 
NYU Taiwan National Yang-Ming University Taipei, Taiwan 
BUCM China Beijing University of Chinese Medicine, Chaoyang, 
China 
 
Figure 5 Top 10 Affiliations in the field of herb drug interactions during 2011-2019. 
Author affiliations were ordered according to publication count and plotted in a bar graph. Full 
affiliations with abbreviations used in graph are given in the table. 
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Table 1 Top 10 authors in the field of herb drug interactions during 2011-2019. Individual 
author publications were counted and indexed into the table to produce a list of top 10 authors 
in the research area during 2011-2019. 
 
 
 
 
 
  
Author 
name 
Author affiliation and country publication 
count  
Ernst, E. Department of Complementary Medicine, School of 
Postgraduate Medicine and Health Sciences, 
University of Exeter, Exeter, United Kingdom 
31 
Huang, M. State Key Laboratory of Bioactive Substance and 
Function of Natural Medicines, Institute of Materia 
Medica, Chinese Academy of Medical Sciences / 
Peking Union Medical College, Beijing 100050, 
China. 
23 
Hou, Y.C. Graduate Institute of Pharmaceutical Chemistry, 
China Medical University, Taichung, 40402, Taiwan. 
22 
Yang, L. Laboratory of Pharmaceutical Resource Discovery, 
Dalian Institute of Chemical Physics, Chinese 
Academy of Sciences, Dalian, China. 
22 
Zhou, S.F. Discipline of Chinese Medicine, School of Health 
Sciences, RMIT University, Victoria, Australia. 
21 
Duan, J.A. Jiangsu Key Laboratory for High Technology 
Research of TCM Formulae, Nanjing University of 
Chinese Medicine, Nanjing 210046, China 
20 
Fang, Z.Z  Laboratory of Pharmaceutical Resource Discovery, 
Dalian Institute of Chemical Physics, Chinese 
Academy of Sciences, Dalian, China. 
19 
Gurley, B.J  Department of Pharmaceutical Sciences, University 
of Arkansas for Medical Sciences, College of 
Pharmacy, Little Rock, AR 72205, USA. 
19 
Tsai, T.H Laboratoire de Toxicologie Cellulaire, EA 4267, IFR 
133, UFR Pharmacie, Place Saint-Jacques, 25030 
Besançon, France. 
19 
Yeung, J.H.K School of Biomedical Sciences, Faculty of Medicine, 
The Chinese University of Hong Kong, Hong Kong, 
China. 
19 
Table 2 Top three publications during 2011-2019 based on the citation count as in Nov 
2019 authors in the field of herb drug interactions. An extensive analysis of original 
research and review articles during the time period was performed to identify the three 
publications with the highest citation count. 
Article Year of 
publishing 
# Citations 
Structure and dynamics of molecular networks: a novel 
paradigm of drug discovery: a comprehensive review. 
Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R. 
Pharmacol Ther. Jun;138(3):333-408.   
2013 445 
A review on therapeutic potential of Nigella sativa: A miracle 
herb. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, 
Siddique NA, Damanhouri ZA, Anwar F. Asian Pac J Trop 
Biomed. 2013 May;3(5):337-52.  
2013 339 
TCMSP: A database of systems pharmacology for drug 
discovery from herbal medicines. Ru J, Li P, Wang J, Zhou W, 
Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, 
Wang Y, Yang L. J Cheminform. 2014 Apr 16;6:13.  
2014 297 
 
  
Table 3 Top 20 publications of all time based on the citation count as in Nov 2019 authors 
in the field of herb drug interactions. Top research and review articles of all time based on 
citation count on the day of the search with term ‘herb drug interactions’ were collected and 
indexed in the table.  
S. 
No. 
Article Article 
type 
Year of 
publishing 
# 
Citations 
1 Danshen: An overview of its chemistry, 
pharmacology, pharmacokinetics, and clinical 
use. Zhou L, Zuo Z, Chow MS. J Clin 
Pharmacol. 2005 Dec;45(12):1345-59. 
Review 2005 931 
2 Herb-drug interactions. Fugh-Berman A. Lancet. 
2000 Jan 8;355(9198):134-8.  
Review 2000 901 
3 Complementary/ alternative medicine use in a 
comprehensive cancer center and the 
implications for oncology. Richardson MA, 
Sanders T, Palmer JL, Greisinger A, Singletary 
SE. J Clin Oncol. 2000 Jul;18(13):2505-14. 
Research 2000 778 
4 Herbal medicines and perioperative care. Ang-
Lee MK, Moss J, Yuan CS. JAMA. 2001 Jul 
11;286(2):208-16.  
Review 2001 730 
5 Herbal medicinals: Selected clinical 
considerations focusing on known or potential 
drug-herb interactions. Miller LG. Arch Intern 
Med. 1998 Nov 9;158(20):2200-11.  
Review 1998 692 
6 Synergy and other interactions in 
phytomedicines. Williamson EM. 
Phytomedicine. 2001 Sep;8(5):401-9. 
Review 2001 557 
7 Interactions between herbal medicines and 
prescribed drugs: A systematic review. Izzo AA, 
Ernst E. Drugs. 2001;61(15):2163-75. 
Review 2001 553 
8 Pharmacokinetic interaction of digoxin with an 
herbal extract from St John’s wort (Hypericum 
perforatum). Johne A, Brockmöller J, Bauer S, 
Maurer A, Langheinrich M, Roots I. Clin 
Pharmacol Ther. 1999 Oct;66(4):338-45. 
Research 1999 524 
9 Free-radical scavenging action of medicinal 
herbs from Ghana: Thonningia sanguinea on 
experimentally-induced liver injuries. Gyamfi 
MA, Yonamine M, Aniya Y. Gen Pharmacol. 
1999 Jun;32(6):661-7. 
Research 1999 495 
10 Harmless herbs? A review of the recent 
literature. Ernst E. Am J Med. 1998 
Feb;104(2):170-8.  
Review 1998 490 
11 A genetic framework of the control of cell 
division and differentiation in the root meristem. 
Dello Ioio R, Nakamura K, Moubayidin L, 
Perilli S, Taniguchi M, Morita MT, Aoyama T, 
Research 2008 486 
Costantino P, Sabatini S. Science. 2008 Nov 
28;322(5906):1380-4 
12 Herb-drug interactions: A literature review. Hu 
Z, Yang X, Ho PC, Chan SY, Heng PW, Chan 
E, Duan W, Koh HL, Zhou S. Drugs. 
2005;65(9):1239-82. 
Review 2005 482 
13 Structure and dynamics of molecular 
networks: a novel paradigm of drug 
discovery: a comprehensive review. 
Csermely P, Korcsmáros T, Kiss HJ, London 
G, Nussinov R. Pharmacol Ther. 
Jun;138(3):333-408.   
Review 2013 445 
14 The risk-benefit profile of commonly used 
herbal therapies: Ginkgo, St. John’s wort, 
ginseng, echinacea, saw palmetto, and kava. 
Ernst E. Ann Intern Med. 2002 Jan 1;136(1):42-
53. 
Review 2002 407 
15 Interactions between herbal medicines and 
prescribed drugs: an updated systematic review. 
Izzo AA, Ernst E. Drugs. 2009;69(13):1777-98 
Review 2009 396 
16 Cardiovascular effects of Danshen. Cheng TO. 
Int J Cardiol. 2007 Sep 14;121(1):9-22. 
Review 2007 369 
17 Herbal remedies in the United States: Potential 
adverse interactions with anticancer agents. 
Sparreboom A, Cox MC, Acharya MR, Figg 
WD.  
J Clin Oncol. 2004 Jun 15;22(12):2489-503. 
Review 2004 354 
18 A review on therapeutic potential of Nigella 
sativa: A miracle herb. Ahmad A, Husain A, 
Mujeeb M, Khan SA, Najmi AK, Siddique 
NA, Damanhouri ZA, Anwar F. Asian Pac J 
Trop Biomed. 2013 May;3(5):337-52.  
Review 2013 339 
19 Degradation of ginsenosides in humans after oral 
administration. Tawab MA, Bahr U, Karas M, 
Wurglics M, Schubert-Zsilavecz M. Drug Metab 
Dispos. 2003 Aug;31(8):1065-71. 
Research 2003 337 
20 Investigation of the interaction between 
Berberine and human serum albumin. Hu YJ, 
Liu Y, Xiao XH. Biomacromolecules. 2009 Mar 
9;10(3):517-21. 
Research 2009 336 
 
 
 
 
